VALEANT PHARMACEUTICALS INTL
VRX
VRX was delisted on the 27th of September, 2010.
3 hedge funds and large institutions have $1.03M invested in VALEANT PHARMACEUTICALS INTL in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
19% less capital invested
Capital invested by funds: $1.26M → $1.03M (-$236K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMG
Monetary Management Group
St Louis,
Missouri
|
+$58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$68.8K |
VRX Hedge Fund Activity: Q3 2015 in Review
3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q3 2015, worth a combined $1.03M — down 19% from $1.26M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VRX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Monetary Management Group, opening a new position worth an estimated $58K. The largest seller was Colony Group, cutting an estimated $68.8K.
- 3 institutional investors held VALEANT PHARMACEUTICALS INTL (VRX) as of Q3 2015, up from 1 in Q2 2015.
- Funds reported $1.03M of VALEANT PHARMACEUTICALS INTL stock for Q3 2015, down 19% quarter-over-quarter.
- 2 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q3 2015 and 0 closed out, a net change of +2 holders.
- The largest VALEANT PHARMACEUTICALS INTL buyer in Q3 2015 was Monetary Management Group, an estimated $58K added.
- The largest VALEANT PHARMACEUTICALS INTL seller in Q3 2015 was Colony Group, an estimated $68.8K sold.
Based on aggregated 13F filings for Q3 2015.